Abstract
Following the detection and clinical approval of cytostatic platinum complexes, antitumor activity was revealed during the past years for numerous other quite different inorganic and organometallic compounds. Metallocene and metalliceniurn complexes represent examples of organometallic compounds containing early or medium transition metals. Their antiproliferative activity has been detected in 1979 and 1984, respectively (1–3). Together with copper and gold complexes (4,5) and main group element compounds (6–9), metallocene and metallicenium complexes belong to the class of non-platinum group metal antitumor agents (10).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Köpf, H. and Köpf-Maier, P. Angew. Chem. 91: 509, 1979;
Köpf, H. and Köpf-Maier, P. Angew. Chem. Int. Ed. Engl. 18: 477–478, 1979.
Köpf-Maier, P. and Köpf, H. Z. Naturforsch. 34b: 805–807, 1979.
Köpf-Maier, P., Köpf, H. and Neuse, E. J. Cancer Res. Clin. Oncol. 108: 336–340, 1984.
Elo, E.O. and Lumme, P.O. Cancer Treat. Rep. 69: 1021–1022, 1984.
Berners-Price, S.J., Mirabelli, C.K., Johnson, R.K., Mattern, M.R., McCabe, F.L., Faucette, L.F., Sung, C.M., Mong, S.M., Sadler, P.J. and Crooke, S.T. Cancer Res. 46: 5486–5493, 1986.
Adamson, R.H., Canellos, G.P. and Sieber, S.M. Cancer Chemother. Rep. (Part 1) 59: 599–610, 1975.
Mulinos, M.G. and Amin, P. Fed. Proc. 39: 747, 1980.
Kumano, N., Nakai, Y., Ishikawa, T., Koinumaro, S., Suzuki, S. and Konno, K. Sci. Rep. Res. Inst. Tohoku Univ. 25: 89–95, 1978.
Crowe, A.J., Smith, P.J. and Atassi, G. Chem. Biol. Interact. 32: 171–178, 1980.
Köpf-Maier, P. and Köpf, H. Chem. Rev., in press.
Köpf-Maier, P., Wagner, W., Hesse, B. and Köpf, H. Eur. J. Cancer 17: 665–669, 1981.
Köpf-Maier, P., Preiß, F., Marx, T., Klapötke, T. and Köpf, H. Anticancer Res. 6: 33–38, 1986.
Köpf-Maier, P. and Köpf, H. Arzneim.-Forsch./Drug Res., in press.
Toney, J.H., Rao, L.N., Murthy, M.S. and Marks, T.J. J. Breast Cancer Res. Treat. 6: 185, 1985.
Murthy, M.S., Toney, J.H., Rao, L.N., Kuo, L.Y. and Marks, T.J. Proc. Am. Assoc. Cancer Res. 27: 279, 1986.
Köpf-Maier, P., Moormann, A. and Köpf, H. Eur. J. Cancer Clin. Oncol. 21: 853–857, 1985.
Köpf-Maier, P. J. Cancer Res. Clin. Oncol., in press.
Köpf-Maier, P. and Funke-Kaiser, P. Toxicol. 38: 81–90, 1986.
Köpf-Maier, P. and Gerlach, S. J. Cancer Res. Clin. Oncol. 111: 243–247, 1986.
Köpf-Maier, P. and Gerlach, S. Anticancer Res. 6: 235–240, 1986.
Köpf-Maier, P. and Erkenswick, P. Toxicol. 33: 171–181, 1984.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Köpf-Maier, P. (1988). Organometallic Titanocene and Ferricenium Complexes: Antitumor and Toxicologic Properties. In: Nicolini, M. (eds) Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. Developments in Oncology, vol 54. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1717-3_66
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1717-3_66
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8967-8
Online ISBN: 978-1-4613-1717-3
eBook Packages: Springer Book Archive